[Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
作者信息
Gerc V, Numić N
出版信息
Med Arh. 1980;34(1):51-9.
PMID:7007752
Abstract
摘要
相似文献
1
[Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
Med Arh. 1980;34(1):51-9.
2
[An example of an acceptable combination in the treatment of arterial hypertension].
Sem Hop. 1978 Feb;54(4):201-6.
3
[Ergometric studies for supplementary evaluation of antihypertensive therapy].
Verh Dtsch Ges Inn Med. 1977;83:325-7.
4
[Treatment of hypertension with a drug combination, consisting of bemetizide, triamterene, dihydralazine and bupranolol (author's transl)].用包含苄氟噻嗪、氨苯蝶啶、双肼屈嗪和布普洛尔的药物组合治疗高血压（作者译）
Wien Klin Wochenschr. 1982 Jan 8;94(1):25-8.
5
6
[Treatment of hypertension with clofelin and adelfan-esidrex].
Vrach Delo. 1980 Sep(9):60-2.
7
Hydralazine and beta-adrenergic blockade in the treatment of hypertension.肼屈嗪与β-肾上腺素能阻滞剂治疗高血压
Ann Clin Res. 1974 Dec;6(6):341-6.
8
[Therapeutic equivalent of a single and divided daily dose of 2 Tri-Torrat coated tablets].
MMW Munch Med Wochenschr. 1984 Feb 17;126(7):181-4.
9
[Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
Arq Bras Cardiol. 1980 May;34(5):409-14.
10
The influence of the acetylator phenotype for the clinical use of dihydralazine.
Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23 Suppl 1:S74-8.
Zotero 插件